Therapeutic antibody based fusion proteins

Details Therapeutic antibody based fusion proteins Therapeutic antibody based fusion proteins

1994-05-23

1997-07-08

Budens, Robert D.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

4241381, 4241551, 5303873, 5303877, A61K 39395

Patent

active

056458355

ABSTRACT:
The present invention relates to methods of providing a targeted, amplified antitumor immune response using antibody-based fusion proteins. More specifically, the invention relates to the use of antibody-based fusion proteins comprising an immunoglobulin portion capable of binding to a tumor antigen linked to a biologically active lymphokine. The immunoglobulin portion targets the fusion protein to the site of the tumor cells and the lymphokine portion stimulates the proliferation of immune T cells at the site of the tumor cells, thereby amplifying the anti-tumor immune response. In preferred embodiments of the invention, the immunoglobulin portion of the fusion protein is derived from the L6 monoclonal antibody and/or the lymphokine is interleukin-2.

REFERENCES:
patent: 4935352 (1990-06-01), Koichi et al.
patent: 5095096 (1992-03-01), Miki et al.
patent: 5314995 (1994-05-01), Fell et al.
Hird et al., "Immunotherapy with Monoclonal Antibodies," in Genes and Cancer, Carney et al., Eds., John Wiley & Sons Ltd., 1990.
Howard et al., "T-Cell-Derived Cytokines and Their Receptors," in Fundamental Immunology, 3rd Ed., W.E. Paul, Ed., Raven Press, 1993.
Waldmann, Monoclonal antibodies in diagnosis and therapy. Science, vol. 252, pp. 1657-1662, 1991.
Manson, Anti-tumor immune responses of the tumor bearing host: the case for antibody mediated immunologic enhancement. Clin. Immunol. Immunopathol. vol. 72, No. 1, pp. 1-8, 1994.
Osbund et al., Problems in the investigational and clinical use of cancer immuntherapy. Immunol. Today, vol. 11, No. 6, pp. 103-105.
Chaudhary et al., 1989, Nature 339: 394-397.
Hellstrom et al., 1984, in Monoclonal Antibodies And Cancer, Wright et al. (eds.), Marcel Dekker, Inc. NY, pp. 31-47 ("Hellstrom I").
Hellstrom et al., 1985, in Monoclonal Antibodies For Cancer Detection And Therapy, Baldwin et al. (eds.), Academic Press, NY, pp. 17-51 ("Hellstrom II").
Kelley et al., 1988, Proc. Natl. Acad. Sci. USA 85: 3980-3984.
Kirkman et al., 1989, Transplantation 47 (No. 2): 327-330.
Kiyokawa et al., 1989, Cancer Res. 49: 4042-4046.
Morrison et al., 1984, Proc. Natl. Acad. Sci. USA 81: 6851-6855 ("Morrison I").
Morrison, 1985, Science 229: 1202-1207 ("Morrison II").
Murphy, 1988, in Immunotoxins, Frankel (ed.), Kluwer Academic Publshers, pp. 123-140.
Neuberger et al., 1984, Nature 312: 604-608.
Roberge et al., 1989, J. Immunol. 143 (No. 11): 3498-3502.
Sahagan et al., J. Immunol. 1317 (No. 3): 1066-p1074.
Schnee et al., 1987, Proc. Natl. Acad. Sci. USA 84: 6904-6908.
Sun et al., 1987, Proc. Natl. Acad. Sci. USA 84: 214-218.
Walz et al., Jan. 1990, Transplantation 49 (No. 1): 198-201.
Williams et al., 1986, Gene 43: 319-324.
Sasada et al, Cell Structure and Function, 13, 1988, pp. 129-141.
Senoo et al, CA, vol. 104, 1986, #220129e.
Gross et al, PNAS 86, 1989, pp. 10024-10028.
Ashenozi et al, CA, vol. 116(3) 1991 #19532h.
Morrison et al, CA 116(3) 1991, #19660a.
Schull et al, PNAS, vol. 84, 1987, pp. 6904-6908.
Traunecker et al, Nature, 339, 1989, pp. 68-70.

Affiliated with

Also associated with

Rating

Therapeutic antibody based fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic antibody based fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic antibody based fusion proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2407571